门诊老年患者潜在不适当用药评价

doi:10.19803/j.1672-8629.2021.11.20

摘要/Abstract

摘要： 目的评价某三级医院门诊老年患者潜在不适当用药（potentially inappropriate medication, PIM）情况,为提升老年人用药安全提供建议。方法根据《中国老年人潜在不适当用药判断标准》（2017年版）,对在2018年8月至10月间就诊者,随机挑选30 d的处方,共2 411例年龄≥60岁门诊老年患者用药进行分析。结果 2 411例研究对象中,平均年龄（71.06±8.13）岁,平均患病（6.59±5.16）种,平均药品（2.96±2.30）种。507例（21.03%）患者存在584项PIM,46例（1.91%）患者存在49项与疾病相关的PIM。结论该院门诊老年患者存在PIM较为严重,药师应加强老年人处方前置审核工作,加大对老年人用药指导力度,重点关注高龄、患多种疾病、使用多种药物的患者,从而规避用药风险,保障老年人合理用药。

关键词: 潜在不适当用药, 老年人, 合理用药

Abstract: Objectiv eTo evaluate the potentially inappropriate medications (PIM) in elderly outpatients, and recommend ways to improve the safety of medication for the elderly. Methods According to the 2017 edition of criteria for potentially inappropriate medications for older adults in China, medications for 2 411 elderly outpatients aged 60 or above were analyzed. Results The average age of the 2 411 enrolled outpatients was with random 30-day prescriptions from August to October 2018 (71.06±8.13) years and the average number of types of diseases was (6.59±5.16). For each patient, (2.96±2.30) types of medicines were being used. 507 patients (21.03%) experienced 584 PIM, and there were 46 cases of PIM (1.91%) related to diseases. Conclusion PIM are becoming more prevalent in elderly patients. Pharmacists should pre-examine prescriptions for the elderly more prudently and give more guidance to the elderly. We should also focus on patients who are elderly, suffer from multiple diseases, and use multiple drugs so as to avoid the risk of drug use and ensure the rational use of drugs by the elderly.

Key words: potentially inappropriate medication, elderly, rational use of drugs

中图分类号:

R969.3

张捷, 毛乾泰, 艾超. 门诊老年患者潜在不适当用药评价[J]. 中国药物警戒, 2021, 18(11): 1087-1090.

ZHANG Jie, MAO Qiantai, AI Chao. Evaluation of Potentially Inappropriate Medications in Elderly Outpatients[J]. Chinese Journal of Pharmacovigilance, 2021, 18(11): 1087-1090.

参考文献

[1] Zhang P.The impact of population age structure, household savings rate and balance sheet on the banking system in China[J]. Journal of Jilin Financial Research(吉林金融研究), 2008, 11(1): 6-9.
[2] O'Mahony D, O'Sullivan D, Byrne S, et al. STOPP /START criteria for potentially inappropriate prescribing in older people: version 2[J]. Age Ageing, 2015, 44(2): 213-218.
[3] Samuel MJ.American Geriatrics Society 2015 updated Beers criteria for potentially inappropriate medication use in older adults[J]. J Am Geriatr Soc, 2015, 63(11):2227-2246.
[4] Chen ZY, Liu LG, Tu DH, et al.Assessment of potentially inappropriate medication in community-dwelling elderly patients based on three criteria[J]. Chinese Journal of New Drugs and Clinical Remedies(中国新药与临床杂志), 2018, 37(12): 700-706.
[5] Zhang XL, Wang YQ, Yan Y, et al.Development of primary standard of potentially inappropriate medication in Chinese aged people under morbid state[J]. Adverse Drug Reactions Journal(药物不良反应杂志), 2014, 16(2): 79-85.
[6] Yan Y, Wang YQ, Shen Q, et al.Development of a list of potentially inappropriate medication for the Chinese aged people[J]. Adverse Drug Reactions Journal(药物不良反应杂志), 2015, 17(1): 19-26.
[7] Rational Drug Use Branch of Chinese Association of Geriatric Research. Criteria of potentially inappropriate medications for older adults in China[J]. Adverse Drug Reactions Journal(药物不良反应杂志)), 2018, 20(1): 2-8.
[8] Yuan LP, Wei JY, Wan LY, et al.Survey of potentially inappropriate medications of elderly inpatients in a pneumology department[J]. Chinese Journal of New Drugs(中国新药杂志), 2019, 28(24): 3042-3045.
[9] He L.Analysis of irrational drug use in elderly inpatients[J]. Chinese Journal of Clinical Rational Drug Use(临床合理用药杂志), 2019, 12(12): 101-102.
[10] Zeng JJ, Su YF, Weng YY.Analysis of potential inappropriate medication for elderly patients in the outpatient and emergency department of our hospital[J]. Chinese Journal of Rural Medicine and Pharmacy(中国乡村医药), 2019, 26(21): 31-33.
[11] Yang QY, Liu X, Pan Q, et al.Medication risk and safety evaluation for elderly patients in the nursing community by 2019 Beers criteria[J]. World Clinical Drugs(世界临床药物), 2019, 40(9): 664-670.
[12] Gu P, Li ZY, Mi JL, et al.Analysis of potentially inappropriate medication and risk factors in older inpatients[J]. Pharmaceutical Care and Research(药学服务与研究), 2019, 19(5): 345-348.
[13] Liu YL, Sun Y, Fang X, et al.Analysis of potentially inappropriate medications in 317 elderly inpatients[J]. China Pharmaceuticals(中国药业), 2019, 28(19): 85-89.
[14] Wang P, Cui YJ, Zhai XL, et al.Relationship between potentially inappropriate medications and physical function in hospitalized elderly patients[J]. Practical Geriatrics(实用老年医学), 2019(9): 912-916.
[15] Ruan SF, Wu XL.Analysis of irrational drug use in elderly inpatients based on the criteria of potentially inappropriate medications for older adults in China[J]. Pharmacy Today(今日药学), 2019, 29(4): 263-266.
[16] Yin YM.Comparison of the effects of clopidogrel and aspirin for elderly patients with coronary heart disease[J]. Contemporary Medical Symposium(当代医药论丛), 2018, 16(23): 111-113.
[17] Xu XJ, Liu S, Liu YY, et al.Efficacy of clopidogrel in elderly patients with transient ischemic attack and disturbance of consciousness[J]. Journal of Preventive Medicine of Chinese People's Liberation Army(解放军预防医学杂志), 2019, 37(1): 46-48.
[18] Gao Y.Observation of the effect of clopidogrel combined with aspirin in the treatment of elderly transient ischemic attack[J]. Cardiovascular Disease Electronic Journal of Integrated Traditional Chinese and Western Medicine(中西医结合心血管病杂志), 2018, 6(35): 58-58.
[19] Li M, Zhou LJ, Zhan F, et al.Based on CYP2C19 genotype of clopidogrel and ticagrelor treatment of acute coronary syndromes individualized drug analysis[J]. Chinese Pharmaceutical Journal(中国药学杂志), 2019, 54(9): 753-760.
[20] Sleep Disorder Group, Neurology Branch of Chinese Medical Association. Guidelines for the diagnosis and treatment of insomnia in Chinese adults[J]. Chinese Journal of Neurology(中华神经科杂志), 2018, 51(5): 324-335.
[21] Li A, Zhang B.Survey and consideration on safety status of traditional Chinese medicine application in 685 primary healthcare workers[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2018, 15(12): 721-727.
[22] Endocrinology and Metabolism Branch of Chinese Association of Geriatric Research. Expert consensus on risk management of polypharmacy in elderly[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2018, 15(10): 627-640.